Vor Biopharma Inc.
VOR
$0.572
$0.02835.21%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -116.91M | -112.46M | -118.09M | -120.23M | -117.86M |
| Total Depreciation and Amortization | 3.53M | 3.56M | 3.60M | 3.60M | 3.49M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.72M | 12.88M | 12.48M | 12.94M | 13.43M |
| Change in Net Operating Assets | 5.00K | -3.59M | -2.22M | -2.79M | 650.00K |
| Cash from Operations | -99.66M | -99.62M | -104.24M | -106.49M | -100.29M |
| Capital Expenditure | -229.00K | -268.00K | -699.00K | -1.09M | -1.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.09M | 107.53M | 148.53M | 109.57M | 72.08M |
| Cash from Investing | 96.86M | 107.26M | 147.83M | 108.48M | 71.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 56.05M | 456.00K | 741.00K | 1.48M | 4.84M |
| Repurchase of Common Stock | -333.00K | -325.00K | -475.00K | -969.00K | -1.19M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.33M | 0.00 | 0.00 | 0.00 | -717.00K |
| Cash from Financing | 53.39M | 131.00K | 266.00K | 515.00K | 2.94M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.59M | 7.77M | 43.86M | 2.51M | -26.35M |
